Sharma Medical Consultants AB

Active
559418-7352Limited company (AB)Registered 2023ASKIM

Key figures

683 963 kr
Revenue 2024/25
+113,1%
Average annual growth 2022/23–2024/25
0200 k400 k600 k800 k2022/232023/242024/25

Key figures

2024/25

Summary: Sharma Medical Consultants AB

What kind of company is it?

Sharma Medical Consultants AB (org. no. 559418-7352) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Askim. Industry according to Statistics Sweden: general primary medical practice activities (SNI 86211).

How is the company doing financially?

Net sales in financial year 2025 were 683 963 kr. From 2023 to 2025, net sales grew by an average of 113 % per year. Net profit for 2025 was 474 711 kr (69,4 % of net sales). The company was profitable in 2 of the 3 reported financial years. At the end of financial year 2025, total assets were 765 758 kr and equity 499 764 kr (equity ratio 65,3 %). The annual report for 2025 proposes a dividend of 400 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2024/25

Proposed dividend 400 000 kr.

History
2024/25400 000 kr
2022/23100 000 kr
Summary of annual reports2023–2025
2022/232023/242024/25
Sales revenue150 5760683 963
Profit for the reporting year111 817−37 264474 711
Retained earnings of previous periods———
Total assets201 60515 488765 758
Total liabilities64 78815 935265 994
Total equity136 817−447499 764
Employees———
Proposed dividend100 000—400 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.